This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,244.38 firm fixed-price delivery order covers the supply of Pulmozyme 1 mg/ml ampules, a specialty medication, with a completion date of December 24, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.
This contract award was not designated with any set-aside requirements, indicating open competition. As a major pharmaceutical distributor, AmerisourceBergen plays a critical role in supplying essential medical products to federal government agencies, including the military and veterans' healthcare systems.
Generated 3/24/25, 9:54 AM